TipRanks
Bukwang Pharmaceutical Co., Ltd. (KR:003000)
:003000
South Korea Market
003000
Bukwang Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Bukwang Pharmaceutical Co., Ltd. (003000) Ratios

― Followers

Bukwang Pharmaceutical Co., Ltd. Ratios

KR:003000's free cash flow for Q2 2026 was ₩0.45. For the 2026 fiscal year, KR:003000's free cash flow was decreased by ₩ and operating cash flow was ₩0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.33 2.59 5.76 2.61 4.90
Quick Ratio
 1.87 2.15 4.58 2.02 4.04
Cash Ratio
 0.91 0.33 2.55 1.55 1.92
Solvency Ratio
 0.11 0.11 0.01 -0.14 0.02
Operating Cash Flow Ratio
 0.03 0.16 0.97 -0.11 0.37
Short-Term Operating Cash Flow Coverage
 0.04 0.23 263.93 -48.25 0.00
Net Current Asset Value
₩ 133.70B₩ 144.25B₩ 74.70B₩ 59.43B₩ 89.66B
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.16 0.21 0.19 <0.01
Debt-to-Equity Ratio
 0.24 0.24 0.33 0.35 <0.01
Debt-to-Capital Ratio
 0.19 0.19 0.25 0.26 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.24 0.26 <0.01
Financial Leverage Ratio
 1.40 1.47 1.53 1.90 1.52
Debt Service Coverage Ratio
 0.21 0.31 1.08 -6.54 0.95
Interest Coverage Ratio
 -10.99 3.63 0.25 -9.85 -0.13
Debt to Market Cap
 0.20 0.21 0.25 0.18 <0.01
Interest Debt Per Share
 815.00 853.76 1.26K 1.22K 39.31
Net Debt to EBITDA
 -1.40 2.09 -1.40 2.28 -17.31
Profitability Margins
Gross Profit Margin
45.89%47.69%46.44%39.74%41.61%
EBIT Margin
5.41%7.05%2.20%-28.40%-0.12%
EBITDA Margin
7.79%9.79%4.76%-24.99%2.56%
Operating Profit Margin
5.41%7.05%1.01%-29.78%-0.12%
Pretax Profit Margin
4.05%3.18%-1.85%-31.42%-0.54%
Net Profit Margin
4.14%6.26%-1.65%-24.88%-1.30%
Continuous Operations Profit Margin
4.11%6.19%-2.16%-27.32%-2.23%
Net Income Per EBT
102.35%196.88%88.95%79.18%239.61%
EBT Per EBIT
74.73%45.11%-183.57%105.53%447.84%
Return on Assets (ROA)
1.91%2.50%-0.71%-7.30%-0.62%
Return on Equity (ROE)
2.64%3.68%-1.08%-13.84%-0.94%
Return on Capital Employed (ROCE)
3.30%3.69%0.48%-11.31%-0.06%
Return on Invested Capital (ROIC)
2.69%3.05%0.48%-9.82%-0.06%
Return on Tangible Assets
1.93%2.53%-0.72%-7.48%-0.63%
Earnings Yield
2.22%3.37%-0.84%-7.25%-0.40%
Efficiency Ratios
Receivables Turnover
 5.26 6.59 6.52 3.28 2.17
Payables Turnover
 10.04 14.39 16.94 32.04 6.74
Inventory Turnover
 2.19 2.01 2.06 1.34 2.89
Fixed Asset Turnover
 1.46 1.38 1.13 1.03 1.54
Asset Turnover
 0.46 0.40 0.43 0.29 0.48
Working Capital Turnover Ratio
 1.29 1.13 0.99 0.76 1.07
Cash Conversion Cycle
 199.86 211.50 211.80 373.40 240.43
Days of Sales Outstanding
 69.39 55.38 55.98 111.43 168.15
Days of Inventory Outstanding
 166.82 181.49 177.37 273.36 126.40
Days of Payables Outstanding
 36.36 25.37 21.55 11.39 54.12
Operating Cycle
 236.21 236.87 233.35 384.79 294.55
Cash Flow Ratios
Operating Cash Flow Per Share
 34.69 187.33 501.96 -153.50 240.47
Free Cash Flow Per Share
 -45.56 113.03 463.80 -194.65 167.57
CapEx Per Share
 80.24 74.30 38.16 41.15 72.90
Free Cash Flow to Operating Cash Flow
 -1.31 0.60 0.92 1.27 0.70
Dividend Paid and CapEx Coverage Ratio
 0.17 1.51 13.15 -3.73 1.39
Capital Expenditure Coverage Ratio
 0.43 2.52 13.15 -3.73 3.30
Operating Cash Flow Coverage Ratio
 0.04 0.23 0.43 -0.13 17.69
Operating Cash Flow to Sales Ratio
 0.02 0.09 0.21 -0.08 0.09
Free Cash Flow Yield
-1.10%2.99%10.10%-3.08%1.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 67.93 24.90 -118.94 -13.80 -250.60
Price-to-Sales (P/S) Ratio
 1.88 1.86 1.96 3.43 3.25
Price-to-Book (P/B) Ratio
 1.20 1.09 1.29 1.91 2.36
Price-to-Free Cash Flow (P/FCF) Ratio
 -90.91 33.49 9.90 -32.47 54.07
Price-to-Operating Cash Flow Ratio
 118.20 20.21 9.14 -41.17 37.68
Price-to-Earnings Growth (PEG) Ratio
 -1.35 -0.05 1.30 -0.01 -1.47
Price-to-Fair Value
 1.20 1.09 1.29 1.91 2.36
Enterprise Value Multiple
 22.74 21.10 39.80 -11.45 109.63
Enterprise Value
 381.10B 414.58B 303.54B 360.48B 535.62B
EV to EBITDA
 22.74 21.10 39.80 -11.45 109.63
EV to Sales
 1.77 2.07 1.90 2.86 2.81
EV to Free Cash Flow
 -85.64 37.18 9.56 -27.07 46.69
EV to Operating Cash Flow
 112.48 22.43 8.83 -34.33 32.54
Tangible Book Value Per Share
 3.36K 3.40K 3.47K 3.28K 3.87K
Shareholders’ Equity Per Share
 3.42K 3.46K 3.56K 3.31K 3.85K
Tax and Other Ratios
Effective Tax Rate
 -0.02 -0.95 -0.16 0.13 -3.11
Revenue Per Share
 2.20K 2.03K 2.34K 1.84K 2.79K
Net Income Per Share
 91.18 127.43 -38.58 -458.00 -36.15
Tax Burden
 1.02 1.97 0.89 0.79 2.40
Interest Burden
 0.75 0.45 -0.84 1.11 4.48
Research & Development to Revenue
 0.08 0.12 0.15 0.27 0.13
SG&A to Revenue
 0.24 0.12 0.11 0.18 0.10
Stock-Based Compensation to Revenue
 0.00 <0.01 >-0.01 0.00 <0.01
Income Quality
 0.38 1.47 -11.57 0.34 -15.94
Currency in KRW